Does PIMECROLIMUS Cause Off label use? 113 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Off label use have been filed in association with PIMECROLIMUS (Pimecrolimus). This represents 8.5% of all adverse event reports for PIMECROLIMUS.
113
Reports of Off label use with PIMECROLIMUS
8.5%
of all PIMECROLIMUS reports
0
Deaths
2
Hospitalizations
How Dangerous Is Off label use From PIMECROLIMUS?
Of the 113 reports, 2 (1.8%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PIMECROLIMUS. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does PIMECROLIMUS Cause?
Drug ineffective (349)
Treatment failure (139)
Psoriasis (114)
Pruritus (94)
Erythema (89)
Product use in unapproved indication (86)
Rash (82)
Application site pain (72)
Therapeutic product effect incomplete (65)
Condition aggravated (59)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which PIMECROLIMUS Alternatives Have Lower Off label use Risk?
PIMECROLIMUS vs PIMOZIDE
PIMECROLIMUS vs PINAVERIUM
PIMECROLIMUS vs PINDOLOL
PIMECROLIMUS vs PIOGLITAZONE
PIMECROLIMUS vs PIPAMPERONE